Cytomegalovirus, Inflammation, and Mortality in the US
Author Information
Author(s): Amanda M. Simanek, Jennifer Beam Dowd, Graham Pawelec, David Melzer, Ambarish Dutta, Allison E. Aiello
Primary Institution: University of Michigan
Hypothesis
Does cytomegalovirus (CMV) infection predict all-cause and cardiovascular disease-related mortality in a U.S. population, and does C-reactive protein (CRP) mediate or modify these relationships?
Conclusion
CMV infection is associated with an increased risk of all-cause mortality, particularly among individuals with high CRP levels.
Supporting Evidence
- CMV seropositivity was associated with a 19% increased risk of all-cause mortality after adjusting for confounders.
- Individuals with high CRP levels and CMV seropositivity had a 30.1% higher risk of all-cause mortality.
- The study utilized a nationally representative sample from the NHANES III survey.
Takeaway
People who have had a CMV infection might be more likely to die from all causes, especially if they also have high levels of inflammation in their body.
Methodology
The study used data from the NHANES III survey and employed Cox proportional hazard models to analyze mortality risk associated with CMV serostatus and CRP levels.
Potential Biases
Potential biases may arise from the use of self-reported data and the limitations of the NHANES III dataset.
Limitations
The study could not examine the relationship between CMV antibody levels and CRP due to data limitations, and the use of a public-use mortality file may have introduced data perturbation.
Participant Demographics
Participants were U.S. adults aged 25 and older, with a diverse demographic representation.
Statistical Information
P-Value
0.0358
Confidence Interval
1.01, 1.41
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website